GAMMA Investing’s Vir Biotechnology VIR Stock Holding History

GAMMA Investing’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$52.2K	Buy	5,120 +152	+3%	+$1.45K	﹤0.01%	2269
2026 Q1	$44.5K	Buy	4,968 +2,531	+104%	+$20.2K	﹤0.01%	2253
2025 Q4	$14.7K	Buy	2,437 +797	+49%	+$4.75K	﹤0.01%	2787
2025 Q3	$9.36K	Buy	1,640 +304	+23%	+$1.55K	﹤0.01%	2910
2025 Q2	$6.73K	Sell	1,336 -5,775	-81%	-$31K	﹤0.01%	2996
2025 Q1	$46.1K	Buy	7,111 +5,972	+524%	+$53.1K	﹤0.01%	1848
2024 Q4	$8.36K	Sell	1,139 -292	-20%	-$2.3K	﹤0.01%	2707
2024 Q3	$10.7K	Sell	1,431 -1,427	-50%	-$12.4K	﹤0.01%	2425
2024 Q2	$25.4K	Buy	2,858 +150	+6%	+$1.44K	﹤0.01%	1687
2024 Q1	$27.4K	Buy	2,708 +1,934	+250%	+$19.7K	0.01%	1429
2023 Q4	$7.28K	Buy	+774	New	+$7.07K	﹤0.01%	2063

Other funds holding VIR

Foster Group West Des Moines, Iowa $3.76B AUM 21.29% 1-Year Est. Return

FNY Investment Advisers New York $277M AUM 98.95% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Cedar Mountain Advisors Lake Oswego, Oregon $581M AUM 18.16% 1-Year Est. Return

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return